Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone plus intrathecal bupivacaine versus bupivacaine alone for spinal anesthesia in orthopedic surgery
PACTR202411679781198Phase 2Not yet recruiting
- Sponsor
- Kilimanjaro Christian Medical Centre
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dexamethasone and bupivacaine in None (2 arms), sponsored by Kilimanjaro Christian Medical Centre. Primary endpoints: Total duration of sensory blockade and Total duration of motor blockade. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
dexamethasonebupivacaine
Beyond the preview
Go deeper on PACTR202411679781198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202411679781198.